Company Profile

Stokes Bio is dedicated to the development and application of microfluidic technology to radically improve and enhance life science research and molecular diagnostics. It was founded in 2005 by Mark Davies and Tara Dalton based on technology developed by the Stokes Research Institute.

Stokes Bio develops microfluidics based systems for genetic analysis, particularly for the measurement of gene expression and gene target detection. The systems will be used in basic life science research and in the molecular diagnosis of cancers, pathogen detection and pharma-genomics.

Products under development range from point-of-care diagnostics to high throughput arrays.